Cargando…
Bioinformatics-based identification of miR-542-5p as a predictive biomarker in breast cancer therapy
BACKGROUND: Tamoxifen is the first-line hormone therapy for estrogen receptor alpha positive (ERα+) breast cancer. However, about 40% of patients with ERα + breast cancer who receive tamoxifen therapy eventually develop resistance resulting in a poor prognosis. The aim of this study was to mine avai...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769523/ https://www.ncbi.nlm.nih.gov/pubmed/29371858 http://dx.doi.org/10.1186/s41065-018-0055-7 |